FDA approves first blood test to support Alzheimer’s diagnosis
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood test
Recover your password.
A password will be e-mailed to you.
- Advertisement -
- Advertisement -
Recover your password.
A password will be e-mailed to you.